A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

Bristol-Myers Squibb

Overview

The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

Glucovance (metformin HCl/glyburide)DRUG

or Metformin HCl aloneDRUG

or Glyburide alone.DRUG

Eligibility

Sex: ALLMin age: 20 YearsMax age: 75 Years

Medical Language ↔ Plain English

Adults 20-75 with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, and have an HbA1c greater than 6.7%

Locations (9)

Local Institution

Little Rock, Arkansas, United States

Local Institution

Los Angeles, California, United States

Local Institution

Chicago, Illinois, United States

Local Institution

Indianapolis, Indiana, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.